Pharmacological heme treatment to induce HO-1 reduced MA-ALI/ARDS, improved respiratory function, reduced serum vascular endothelial growth factor (VEGF) levels, and improved vascular permeability in this model [210]. This evidence concerns the gene HMOX1 and acute respiratory distress syndrome.